Illustration: =0.4%, =1.2% n =35 per-arm per-stage Do all - - PowerPoint PPT Presentation

illustration 0 4 1 2 n 35 per arm per stage
SMART_READER_LITE
LIVE PREVIEW

Illustration: =0.4%, =1.2% n =35 per-arm per-stage Do all - - PowerPoint PPT Presentation

Illustration: =0.4%, =1.2% n =35 per-arm per-stage Do all experimental treatments share a common effect? E.g experimental arm estimate y i = + i where Var( i ) is variance exp arm 5 of y i exp arm 4 Use Cochrans Q statistic to


slide-1
SLIDE 1

Illustration: δ=0.4%, σ=1.2% n=35 per-arm per-stage

% change in Hba1c

control arm exp arm 1 exp arm 2 exp arm 3 exp arm 4 exp arm 5

−0.25 0.00 0.25 0.50 0.75 1.00

  • Fixed effect estimate

Do all experimental treatments share a common effect? E.g experimental arm estimate yi = µ + ǫi where Var(ǫi) is variance

  • f yi

Use Cochran’s Q statistic to test null hypothesis. Here, p-value for Q is 0.5: No evidence to reject common effect (µ) hypothesis Pooled ‘fixed effect’ estimate for µ justified Compare pooled estimate’s Confidence intervals to that of control group and declare class effective if no overlap

1 / 3

slide-2
SLIDE 2

Heterogeneity between experimental treatments

% change in Hba1c

control arm exp arm 1 exp arm 2 exp arm 3 exp arm 4 exp arm 5

−0.25 0.00 0.25 0.50 0.75 1.00

  • Fixed effect estimate

Random effects estimate

  • I2=50%

Perhaps treatments don’t share a common effect? E.g experimental arm estimate yi = µi + ǫi where Var(µi) is between arm variation Between arm variation as a propn of total variation: I 2 = 50% Q statistic p-value=0.09 Pooled ‘random-effects’ estimate for µ (= mean of µis) arguably justified likely to be very similar to fixed effect estimate Wider confidence interval to acknowledge extra uncertainty. Lower power, but arguably right model

2 / 3

slide-3
SLIDE 3

Issues surrounding dropped treatments

% change in Hba1c

control arm exp arm 1 exp arm 2 exp arm 3 exp arm 4 exp arm 5

−0.25 0.00 0.25 0.50 0.75 1.00

  • all arms
  • kept arms only

Dropped at stage 1

I2 (all arms) =62% I2 (kept arms) =17%

Assume arm 1 & 4 dropped at interim (after 35 patients) Dropped trials have less precise estimates than kept trials Should we exclude dropped arms when estimating pooled effect? Exclude: PROS: Remaining arm results more homogeneous. Likely to opt for a fixed effect estimate. CONS: Remaining arms potentially biased, throwing away information Include: PROS: Using all available

  • information. CONS: Confidence

interval may still be wider due to use of random effects model.

3 / 3